2m 2m 2m 2m 2m 2m 2m
BRIDGEBIO PHARMA (BBIO)
NASDAQ
$83.76+$0.68 (+0.82%)
Price as of Jul 14, 2026 4:03 AM EDT- $16.8BMarket Cap
- 74.21%1-Year Change
- BiotechnologyIndustry
BRIDGEBIO PHARMA (BBIO)
$83.76+$0.68 (+0.82%)
Earnings Score
Valuation | BBIO | vs History | vs S&P 500 |
|---|---|---|---|
Profitability | -0 | ||
Growth | -0 | ||
Low Earnings Volatility | 1 |
Momentum Score
Valuation | BBIO | vs History | vs S&P 500 |
|---|---|---|---|
3-Month Momentum | -9.08% | ||
12-Month Momentum | 45.05% | ||
3-Month Risk Adjusted Momentum | -56.75% | ||
12-Month Risk Adjusted Momentum | 99.97% |
True Yield
Valuation | BBIO | vs History | vs S&P 500 |
|---|---|---|---|
Dividend Yield | N/A | ||
Net Buyback Yield | 0.57% | ||
Net Debt Paydown Yield | -0.52% |
Financial Health Score
Valuation | BBIO | vs History | vs S&P 500 |
|---|---|---|---|
Ohlson's O-Score | 4 |